von Hippel-Lindau peptide vaccine
Term · Oncology and biomedicine · MLC-T-ONC-017530
A cancer vaccine composed of peptides derived from a tumor-associated protein encoded by a mutated Von Hippel-Lindau (VHL) oncogene. VHL peptide vaccine may stimulate a cytotoxic T cell response against tumor cells expressing the VHL tumor-associated protein.
| Identifier | MLC-T-ONC-017530 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | VHL Peptides; VHL peptide vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017530",
"term": "von Hippel-Lindau peptide vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine composed of peptides derived from a tumor-associated protein encoded by a mutated Von Hippel-Lindau (VHL) oncogene. VHL peptide vaccine may stimulate a cytotoxic T cell response against tumor cells expressing the VHL tumor-associated protein.",
"synonyms": [
"VHL Peptides",
"VHL peptide vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/von-hippel-lindau-peptide-vaccine/"
}
Record 17,333 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.